Home » Depomed to Borrow $15 Million for Hot Flash Drug
Depomed to Borrow $15 Million for Hot Flash Drug
Depomed will borrow $15 million from Oxford Finance Corp. and GE Healthcare Financial Services to help pay for a hot flash treatment program. Menlo Park-based Depomed is developing its drug Gabapentin GR to treat both neuropathic pain and menopausal hot flashes.
San Francisco Business Times
San Francisco Business Times
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May